The X-linked gene GATA1 encodes a 414-amino-acid hematopoietic transcription factor that controls erythroid and megakaryocytic differentiation. Virtually all cases of transient myeloproliferative disease and acute megakaryoblastic leukemia in children with Down syndrome harbor somatic GATA1 mutations typically affecting exon 2 and leading to expression of the short isoform, GATA-1s, which lacks the transcriptional activation domain. Moreover, germline missense mutations in exon 4 of GATA1 that predict alterations of amino acids Val205, Gly208, Arg216 or Asp218 of the N-terminal zinc-finger domain (residues 204-228) have been reported in nine families. [1] [2] [3] [4] [5] [6] [7] [8] [9] One additional family has been found to harbor a germline mutation, GATA1 c.322G4C, which leads to expression of GATA-1s. 10 Consistent with X-linked inheritance and full penetrance, germline GATA1 mutations disrupt hematopoiesis in males who harbor a hemizygous mutant GATA1 allele. In contrast, female heterozygous carriers have no or minor hematopoietic defects such as mild chronic thrombocytopenia. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The spectrum of abnormalities caused by different GATA1 mutations probably depends on the function of the predicted mutant protein such as the ability to associate with cofactor FOG-1.
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Hematologic abnormalities include dyserythropoietic anemia and thrombocythemia (V205M, G208R, D218Y and GATA1s), 1, 3, 9, 10 thrombocytopenia with mild dyserythropoiesis (D218G, G208S), 2, 8 thrombocytopenia with thalassemia (R216Q), 4, 5 congenital erythropoietic porphyria (R216W), 7 and gray platelet syndrome (R216Q). 6 Splenomegaly is noted in some cases 5, 7 and is likely to be due to ineffective and consecutive extramedullary hematopoiesis. To date, only the GATA1 R216Q mutation has been identified in more than one family, [4] [5] [6] hampering phenotype-genotype correlation.
We identified a second family with a GATA1 G208R mutation. The index patient was a male neonate born at term to healthy European non-consanguineous parents. Family history was unremarkable and the mother previously gave birth to a healthy boy. At birth, petechiae and ecchymoses on skin and mucosa as well as enlargement of liver and spleen were noted. Hemoglobin measured 8.9 g/dl, leukocytes 54 900/ml and thrombocytes 54 000/ml. Repeated platelet and packed red blood cell transfusions were administered. A bone marrow smear revealed dyserythropoiesis ( Figure 1 ) and dysmegakaryopoiesis but no increase in blasts. A liver biopsy taken at the age of 16 days revealed siderosis, cholestasis and extramedullary hematopoiesis. Mutation analysis with published methods, 1,10 uncovered a hemizygous G to A transition at nucleotide position c.622 in exon 4 of GATA1 predicting a p.G208R change in the highly conserved N-terminal zinc-finger domain of GATA-1. The patient inherited this allele from his heterozygous mother ( Figure 1 ), who had a hemoglobin level of 11.3 g/dl, mean erythrocyte volume 81 fl, leukocytes 12 700/ml and thrombocytes 172 000/ml. At the time of this report, the patient was 6 months of age and was in stable condition requiring platelet transfusions every week and red packed cell transfusions every second to third week. To obtain the option of hematopoietic stem cells transplantation (HSCT) a donor search has been initiated. The same mutation, GATA1
G208R has been described in another individual with dyserythropoietic anemia and thrombocytopenia who was found to have anemia and thrombocytopenia at birth requiring transfusions. 3 This patient received his last red packed cell transfusion at 5 years of age and the frequency of mucosal and severe bleeding decreased in adulthood. At the age of 17 years he had a hemoglobin level of 9.6 g/dl, mean erythrocyte volume 103 fl and thrombocytes 12 000/ml. 3 Notably, this patient's mother was mildly thrombocytopenic with platelets measuring 140 000/ml. 3 The similar clinical presentation with transfusion-dependent cytopenia at birth underscores the notion of a genotype-phenotype relationship of different GATA1 defects. However, in addition to dyserythropoietic anemia and thrombocytopenia, our patient presented with marked organomegaly. Although bleeding complications in patients with germline GATA1 mutations may decrease with age, 3 this disorder may lead to early death. 2, 9 Notably, in one family with a GATA1 D218Y allele, six affected boys died before the age of 2 years. 9 In cases of GATA1 defects with significant thrombocytopenia and severe bleeding diathesis, HSCT may be warranted. Indeed, related or unrelated HSCT has been performed in a small number of cases. 1, 7, 10 In conclusion, we describe the second family with a GATA1 G208R allele causing congenital dyserythropoietic anemia and thrombocytopenia. Additionally, the affected male showed marked organomegaly. Besides GATA1
G216Q
, the GATA1 G208R allele is the only mutation that has been identified in more than one family. The identification of a larger number of families with these rare mutations that lead to a spectrum of mild to severe hematologic defects will help to perform phenotypegenotype correlations that eventually will facilitate treatment decisions and patient care. The recurrent GATA1 G208R mutation causes congenital dyserythropoietic anemia and thrombocytopenia. A heterozygous germline GATA1 mutation, c.622G4A, is detected in the patient's mother. The patient harbors a hemizygous mutant allele (a). This alteration in exon 4 predicts a G208R change in the N-terminal zinc finger (N) of the protein (TD: transcriptional activation domain; C: C-terminal zinc finger). This mutation locates near residues that are altered by other known germline mutations (red) (b). A bone marrow slide shows severe dyserythropoietic changes (arrows) (c). In myeloid malignancy, a number of recurrent and sporadic rearrangements of 3q26 are associated with transcriptional activation of EVI1 and/or EVI1 chimaeric genes. 1 Recurrent rearrangements include the inv(3)(q21q26) and its variants t(3;3)(q21;q26) and ins(3;3)(q26;q21q26), as well as translocations involving other chromosomes such as the t(3;21)(q26;q22). In general, 3q26 rearrangements are associated with a poor disease prognosis. 2 Given the unfavourable outcome of 3q26 rearrangements, methods for establishing their presence at diagnosis and during treatment or disease progression are highly desirable, particularly when chromosome banding analysis is hampered by low quality or insufficient metaphase cells. To date, however, the wide 3q26 breakpoint region has precluded development of a single fluorescent in situ hybridization (FISH) probe sensitive enough to monitor residual disease. We describe a novel dualcolour FISH probe designed to span the entire 3q26 breakpoint region in a single hybridization, which allowed successful detection and quantification of the level of leukaemic cells in 11 patients with 3q26 rearrangements. Physical mapping data obtained with this probe further support the notion of a degree of rearrangement-specific breakpoint clustering within cytogenetic subgroups of 3q26 abnormality.
The dual-colour EVI1 FISH probe was designed to comprise two differentially labelled DNA contigs flanking the common 3q26 breakpoint region (Figure 1 ). Expected signal patterns from Figure 1 Structure and principle of the EVI1 break-apart fluorescent in situ hybridization (FISH) probe system. The probe is composed of two differentially labelled contigs specific for the 3q26 locus (Kreatech Biotechnologies, Amsterdam, The Netherlands). The most centromeric contig, labelled in green fluorochrome, hybridizes to a region extending 460 kb from the centromeric (3 0 ) end of the EVI1 gene. The second, most telomeric contig, labelled with a red fluorochrome, is specific for a region beginning approximately 500 kb 3 0 of EVI1 and extends 370 kb in a telomeric direction. The distance between the hybridization regions of the two contigs is 530 kb. The breakpoint region associated with 3q26 abnormalities is indicated. The lower portion of the figure shows the principle of the EVI1 break-apart FISH assay with the expected normal and abnormal hybridization patterns. For simplicity, an inv(3)(q21q26) is depicted in the scheme, however, the principles of this approach apply to all 3q26 rearrangements. 
